Kenja - Ingliż - Pharmacy and Poisons Board

medcure healthcare ltd kensia house muranga road - clomiphene 50mg tablets - tablet - clomiphene citrate 50mg - clomifene

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - clomiphene citrate - tablet - 50 milligram(s) - ovulation stimulants, synthetic; clomifene

Malta - Ingliż - Medicines Authority

jv healthcare limited - clomifene citrate - tablet - clomifene citrate 50 mg - sex hormones and modulators of the genital system

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - clomifene citrate, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate; maize starch; povidone - indications: clomiphene citrate is indicated in the treatment of ovulatory failure in patients desiring pregnancy, whose partners have adequate sperm and who have potentially functional hypothalamic-hypophyseal ovarian systems and adequate endogenous oestrogens. impediments to this goal must be excluded or adequately treated before beginning therapy. administration of clomiphene is indicated only in patients with demonstrated ovulatory dysfunction and in whom the following condition apply: 1. demonstration of normal liver function 2. physiological indications of normal or near normal endogenous oestrogen levels should be present (as estimated from vaginal smears, endometrial biopsy, assay of urinary or serum oestrogen or from bleeding in response to progesterone). reduced oestrogen levels, while less favourable, do not prevent successful therapy. 3. clomiphene citrate is not effective in patients with primary pituitary or ovarian failure. it cannot substitute for appropriate therapy of other disturbances leading to ovulatory dysfunction, e.g. diseases of the thyroid or adrenals. 4. patients with abnormal uterine bleeding should be thoroughly evaluated prior to initiating clomiphene therapy. it is most important that neoplastic lesions are detected.

Filippini - Ingliż - FDA (Food And Drug Administration)

pharmasia-cuvest, incorporated - clomifene (as citrate) - tablet - 50mg

Filippini - Ingliż - FDA (Food And Drug Administration)

sanofi-aventis phils inc - clomifene citrate - tablet - 50mg

Filippini - Ingliż - FDA (Food And Drug Administration)

britton distributions, incorporated; distributor: britton distributions, incorporated - clomifene citrate - tablet - 50mg

Filippini - Ingliż - FDA (Food And Drug Administration)

atlantic pharmaceuticals, inc.; distributor: atlantic pharmaceuticals, inc. - clomifene citrate - tablet - 50 mg

Filippini - Ingliż - FDA (Food And Drug Administration)

sahar int'l trading inc - clomifene citrate - tablet - 50mg

Filippini - Ingliż - FDA (Food And Drug Administration)

stangen pharmaceuticals philippines inc.; distributor: alberta's pride international indigo, inc. - clomifene citrate - tablet - 50mg